Prevalence and impact of non-alcoholic fatty liver disease in patients with papillary thyroid carcinoma.

doi:10.1007/s12020-023-03312-y

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Prevalence and impact of non-alcoholic fatty liver disease in patients with papillary thyroid carcinoma.

Endocrine - 1 Jun 2023

Xiao Renyi, Ni Chunjue, Cai Yefeng, Zhou Yili, Gong Xiaohua, Xie Keyue, You Jie

Abstract excerpt

PURPOSE: Papillary thyroid carcinoma (PTC) is the most common thyroid cancer. Non-alcoholic Fatty Liver Disease (NAFLD) was possibly among the risk factors for thyroid carcinoma. It is uncertain whether NAFLD is associated with the aggressiveness of PTC. METHODS: We obtained data on patients with PTC who had undergone surgery at the First Affiliated Hospital of Wenzhou Medical University between January 2020 and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cross-Sectional Studies
Share to Lymphatic Metastasis
Share to Mutation
Share to Non-alcoholic Fatty Liver Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prevalence

Share to Proto-Oncogene Proteins B-raf

Share to Thyroid Cancer, Papillary

Share to Thyroid Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 36696026
DOI: 10.1007/s12020-023-03312-y
PMCID: PMC9875189

Provenance

PubMed metadata and Literature Corpus relationships.